挑戦的な標的をターゲットにするための新しいパラダイム:先進技術と分子接着剤の劣化剤の将来の方向性
Yifan Zhang1,2, Linlin Li1,2, Jiajia Xu1,2
1State Key Laboratory of Natural Medicines, Jiang Su Key Laboratory of Drug Design & Optimization, China Pharmaceutical University, Nanjing 210009, China.
Molecules (Basel, Switzerland)
|February 13, 2026
まとめ
分子粘着分解剤 (MGD) は,標的型タンパク質分解 (TPD) の新しい治療アプローチを提供します. これらの薬剤は,タンパク質クリアランスのためのE3リガース相互作用を安定させ,薬剤発見の有望性を示しています.
科学分野:
- バイオケミストリー バイオケミストリー
- 薬理学 薬理学とは
- ドラッグ・ディスカバリー・ドリッグ・ディスカバリー・ドリッグ・ディスカバリー・ドリッグ・ディスカバリー
背景:
- 分子粘着分解剤 (MGD) は,標的型タンパク質分解 (TPD) の治療薬の一種である.
- PROTACsとは異なり,MGDはE3リガゼ-標的タンパク質の相互作用を安定させ,分解を誘導します.
- MGDは,小分子サイズと良好な生物利用性を含む薬剤のような好ましい性質を有しています.
研究 の 目的:
- MGDの発見から合理的な設計までの技術的進化を見直す.
- MGD発見戦略を評価し,課題と将来の方向性を議論する.
- 薬剤発見のためのMGDの包括的な概要を提供するために.
主な方法:
- MGDに関する文献の体系的なレビュー.
- MGD発見と最適化技術の批判的評価.
- AIや高通量スクリーニングを含む技術進歩の分析.
主要な成果:
- MGDベースの3つの薬が承認されており,多数の候補薬が開発中です.
- スクリーニング,バイオインフォマティクス,AIの進歩により,MGDの体系的な識別が容易になりました.
- MGDは,標的型タンパク質分解療法における重要な進歩を表しています.
結論:
- MGDは,偶然の発見から合理的な設計へと進歩しました.
- 現在の課題に取り組むことで,MGDの応用が広がるでしょう.
- MGDは,薬剤発見のパラダイムを変革する大きな可能性を秘めています.
関連する概念動画
Regulated Protein Degradation
8.9K
It is vital to regulate the activity of enzymatic as well as non-enzymatic proteins inside the cell. This can be achieved either through creating a balance between their rate of synthesis and degradation or regulating the intrinsic activity of the protein. Both these regulation mechanisms play an essential role in the normal functioning of cells.
Protein degradation plays two important roles in the cells. It helps to protect cells from misfolded or damaged proteins before they lead to a...
Protein degradation plays two important roles in the cells. It helps to protect cells from misfolded or damaged proteins before they lead to a...
8.9K
Targeted Cancer Therapies
9.0K
The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against...
There are several types of targeted therapies against...
9.0K
Targets for Drug Action: Overview
10.5K
Drugs target macromolecules to modify ongoing cellular processes. Primary drug targets include receptors, ion channels, transporters, and enzymes.
Receptors are either membrane-spanning or intracellular proteins, which upon binding a ligand, get activated and transmit the signal downstream to elicit a response. Drugs bind receptors, either mimicking the action of endogenous ligands or blocking the receptor activity to bring about a modified response. Nearly 35% of approved drugs target the G...
Receptors are either membrane-spanning or intracellular proteins, which upon binding a ligand, get activated and transmit the signal downstream to elicit a response. Drugs bind receptors, either mimicking the action of endogenous ligands or blocking the receptor activity to bring about a modified response. Nearly 35% of approved drugs target the G...
10.5K
Target Cell Response to Hormones
5.8K
Hormones intricately bind to receptors on the surface or within target cells, initiating a cascade of cellular responses.
Notably, the cellular response can be regulated by altering the number of receptors expressed in the cell. For example, prolonged exposure to elevated hormone levels results in a gradual decline or down-regulation in the number of receptors for that specific hormone on the cell surface. Conversely, in response to low hormone levels, cells may use up-regulation, producing an...
Notably, the cellular response can be regulated by altering the number of receptors expressed in the cell. For example, prolonged exposure to elevated hormone levels results in a gradual decline or down-regulation in the number of receptors for that specific hormone on the cell surface. Conversely, in response to low hormone levels, cells may use up-regulation, producing an...
5.8K
Pharmacogenomics: Identification of New Drug Targets
3
Advances in genomics have profoundly influenced drug discovery by increasing both the speed and accuracy of pharmaceutical development. Pharmacogenomics, which examines how genetic variation influences drug response, facilitates the identification of novel therapeutic targets and enables patient stratification for personalized treatment. These strategies contribute to improved drug efficacy, minimized adverse effects, and more efficient clinical trial design.Mapping genetic differences...
3
Proteins: From Genes to Degradation
14.6K
Within a biological system, the DNA encodes the RNA, and the nucleotide sequence in the RNA further defines the amino acid sequence in the protein. This is referred to as “The Central Dogma of Molecular Biology” - a term coined by Francis Crick. Central dogma is a firm principle in biology that defines the flow of genetic information within any life form. The two fundamental steps in central dogma are - transcription and translation.
Transcription is the synthesis of RNA...
Transcription is the synthesis of RNA...
14.6K


